European Study in Bone Sarcoma Patients Over 40 Years

NCT02986503 · clinicaltrials.gov ↗

COMPLETED

Status

100

Enrollment

NETWORK

Sponsor class

Conditions

Spindle Cell Sarcoma of Bone
Osteosarcoma

Interventions

DRUG: Doxorubicin+cisplatin+ifosfamide
DRUG: Doxorubicin+cisplatin+ifosfamide+methotrexate

Sponsor

Italian Sarcoma Group

Collaborators

[object Object]
[object Object]